Literature DB >> 11700629

Glucosamine for osteoarthritis. Patients' welfare should be primary concern.

D Sonnino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700629      PMCID: PMC1121478     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

Authors:  M M Wolfe; D R Lichtenstein; G Singh
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  Glucosamine for osteoarthritis: magic, hype, or confusion? It's probably safe-but there's no good evidence that it works.

Authors:  J Chard; P Dieppe
Journal:  BMJ       Date:  2001-06-16

3.  Subchondral bone should be the main target for the treatment of pain and disease progression in osteoarthritis.

Authors:  P Dieppe
Journal:  Osteoarthritis Cartilage       Date:  1999-05       Impact factor: 6.576

4.  Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee.

Authors:  J B Houpt; R McMillan; C Wein; S D Paget-Dellio
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

5.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

6.  Pharmacokinetics of glucosamine in the dog and in man.

Authors:  I Setnikar; C Giacchetti; G Zanolo
Journal:  Arzneimittelforschung       Date:  1986-04

7.  The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog.

Authors:  George R Dodge; Ravinder R Regatte; Elizabeth A Noyszewski; Jeffery O Hall; Akella V Sharma; D Allen Callaway; Ravinder Reddy
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.